Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
AXON - Axon Enterprise Inc - Stock Price Chart
TickerAXON [NASD, NDX, S&P 500]
CompanyAxon Enterprise Inc
CountryUSA
IndustryAerospace & Defense
Market Cap60.36BEPS (ttm)4.13
P/E187.68EPS this Y4.25%
Forward P/E100.90EPS next Y24.09%
PEG12.07EPS past 5Y218.25%
P/S27.10EPS next 5Y15.55%
P/B23.62EPS Q/Q-37.48%
Dividend-Sales Q/Q31.01%
Insider Own5.39%Inst Own79.78%
Insider Trans-1.10%Inst Trans0.58%
Short Float2.03%EarningsMay 07/a
Analyst Recom1.58Target Price741.92
Avg Volume610.26K52W Range279.02 - 830.21
Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Isner JoshuaPRESIDENTJun 17 '25Sale776.39905702,633268,735Jun 18 04:24 PM
Isner JoshuaOfficerJun 17 '25Proposed Sale776.31905702,558Jun 17 11:31 AM
Mak Jennifer HChief Accounting OfficerJun 13 '25Sale771.817557,88615,240Jun 16 08:15 PM
GARNREITER MICHAELDirectorJun 04 '25Sale760.005,9134,493,88017,740Jun 04 04:30 PM
GARNREITER MICHAELDirectorJun 03 '25Sale760.008766,12024,653Jun 04 04:30 PM
ARQQ - Arqit Quantum Inc - Stock Price Chart
TickerARQQ [NASD]
CompanyArqit Quantum Inc
CountryUnited Kingdom
IndustrySoftware - Infrastructure
Market Cap497.82MEPS (ttm)-1.87
P/E-EPS this Y32.05%
Forward P/E-EPS next Y47.83%
PEG-EPS past 5Y-
P/S2074.24EPS next 5Y-
P/B29.25EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own56.75%Inst Own4.10%
Insider Trans0.00%Inst Trans12.52%
Short Float4.56%EarningsMay 22/b
Analyst Recom1.00Target Price52.00
Avg Volume877.36K52W Range3.72 - 52.79
Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Willcocks PatrickOfficerJun 25 '25Proposed Sale40.133,000120,385Jun 25 11:16 AM
Shiu DanielOfficerJun 23 '25Proposed Sale38.036,500247,183Jun 23 04:43 PM
Leaver AndrewOfficerJun 23 '25Proposed Sale37.5025,000937,500Jun 23 12:36 PM
Willcocks PatrickOfficerJun 23 '25Proposed Sale36.903,000110,700Jun 23 12:17 PM
Willcocks PatrickOfficerApr 02 '25Proposed Sale13.815327,346Apr 02 03:59 PM
RZLV - Rezolve AI PLC - Stock Price Chart
TickerRZLV [NASD]
CompanyRezolve AI PLC
CountryUnited Kingdom
IndustrySoftware - Infrastructure
Market Cap701.77MEPS (ttm)-0.35
P/E-EPS this Y71.93%
Forward P/E-EPS next Y31.93%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.92EPS Q/Q-229.00%
Dividend-Sales Q/Q-
Insider Own69.61%Inst Own0.98%
Insider Trans0.00%Inst Trans-51.84%
Short Float3.75%EarningsMay 28
Analyst Recom1.00Target Price5.65
Avg Volume6.39M52W Range1.07 - 14.50
Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.
IPX - IperionX Ltd ADR - Stock Price Chart
TickerIPX [NASD]
CompanyIperionX Ltd ADR
CountryUSA
IndustryOther Industrial Metals & Mining
Market Cap944.02MEPS (ttm)-1.10
P/E-EPS this Y-564.93%
Forward P/E-EPS next Y30.91%
PEG-EPS past 5Y-41.39%
P/S-EPS next 5Y-
P/B8.83EPS Q/Q-18.61%
Dividend-Sales Q/Q-
Insider Own-Inst Own7.01%
Insider Trans-Inst Trans17.86%
Short Float0.84%EarningsMar 12/a
Analyst Recom1.00Target Price38.21
Avg Volume75.55K52W Range12.27 - 38.93
IperionX Ltd. engages in the development of low carbon titanium for advanced industries, including space, aerospace, electric vehicles and 3D printing. It produces titanium metal powders from titanium scrap at its operational pilot facility in Utah and intends to scale production at a Titanium Demonstration Facility in Virginia. The company was founded by Anastasios Arima and Scott Sparks on May 5, 2017 and is headquartered in Charlotte, NC.
DXYZ - Destiny Tech100 Inc - Stock Price Chart
TickerDXYZ [NYSE]
CompanyDestiny Tech100 Inc
CountryUSA
IndustryAsset Management
Market Cap388.30MEPS (ttm)1.60
P/E22.31EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own10.29%Inst Own4.48%
Insider Trans0.00%Inst Trans-
Short Float17.33%Earnings-
Analyst Recom-Target Price-
Avg Volume521.08K52W Range9.00 - 77.35
Today 10:36AM How Robinhood's dive into stock tokens makes it a 'must own' crypto investment (MarketWatch) -6.30%
Jun-13-25 05:19PM Destiny Tech100 Inc. Reports First Quarter 2025 Results (Business Wire)
Jun-05-25 05:11PM Trump vs. Musk, Trump trade takes tumble: Market Takeaways (Yahoo Finance Video) -12.65% +5.97%
Apr-23-25 12:47PM Weekly Closed-End Fund Roundup: CUBA Jumping On CLO Bandwagon (April 13, 2025) (Seeking Alpha)
Apr-04-25 04:00PM Destiny Tech100 Inc. Reports Fourth Quarter 2024 Results (Business Wire) -12.14% -9.47%
Apr-03-25 09:44AM 5 (More) Bubbles (Seeking Alpha) -7.50%
Nov-26-24 05:30PM Destiny Tech100 Inc. Reports Third Quarter 2024 Results (Business Wire) -8.28%
Aug-30-24 05:00PM Destiny Tech100 Inc. Reports Second Quarter 2024 Results (Business Wire) -11.59%
May-24-24 05:00PM Destiny Tech100 Inc. Announces First Quarter 2024 Net Asset Value (Business Wire) +7.87%
May-20-24 06:00AM The Destiny Tech 100: What You Should Know Before Buying DXYZ Stock (InvestorPlace)
MNPR - Monopar Therapeutics Inc - Stock Price Chart
TickerMNPR [NASD]
CompanyMonopar Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap205.22MEPS (ttm)-3.99
P/E-EPS this Y49.92%
Forward P/E-EPS next Y-46.23%
PEG-EPS past 5Y-15.56%
P/S-EPS next 5Y20.53%
P/B3.83EPS Q/Q26.84%
Dividend-Sales Q/Q-
Insider Own35.15%Inst Own47.19%
Insider Trans-1.53%Inst Trans20.94%
Short Float0.63%EarningsMay 13/b
Analyst Recom1.33Target Price61.00
Avg Volume31.80K52W Range1.72 - 54.30
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tactic Pharma LLC10% OwnerApr 02 '25Sale35.0033,3341,166,690822,255Apr 04 07:27 PM
Tactic Pharma LLC10% OwnerApr 02 '25Proposed Sale35.0033,3341,166,806Apr 02 11:45 AM
Radhakrishnan KarthikChief Financial OfficerOct 28 '24Buy16.251,55025,1881,550Oct 30 04:17 PM
SOAR - Volato Group Inc - Stock Price Chart
TickerSOAR [AMEX]
CompanyVolato Group Inc
CountryUSA
IndustryAirports & Air Services
Market Cap2.51MEPS (ttm)-19.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.03EPS next 5Y-
P/B-EPS Q/Q100.59%
Dividend-Sales Q/Q92.89%
Insider Own53.99%Inst Own1.42%
Insider Trans-2.28%Inst Trans-10.90%
Short Float56.43%Earnings-
Analyst Recom-Target Price-
Avg Volume1.53M52W Range1.25 - 21.49
Volato Group, Inc. is an aviation company, which engages in the provision of aircraft products and other services. Its aircraft include HondaJet and Gulfstream G280. The company was founded by Matthew D. Liotta and Nicholas Cooper on January 7, 2021 and is headquartered in Chamblee, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cooper Nicholas JamesDirectorJun 30 '25Sale1.2721,25826,9133,327,374Jul 01 02:33 PM
Cooper Nicholas JamesDirectorJun 26 '25Sale1.383,1284,3173,350,432Jul 01 02:33 PM
Cooper Nicholas JamesDirectorJun 27 '25Sale1.291,8002,3223,348,632Jul 01 02:33 PM
Cooper Nicholas JamesDirectorJun 26 '25Proposed Sale1.4733,21548,826Jun 26 12:24 PM
Liotta MatthewChief Executive OfficerFeb 25 '25Option Exercise0.002,9030282,167May 09 05:10 PM
KLTO - Klotho Neurosciences Inc - Stock Price Chart
TickerKLTO [NASD]
CompanyKlotho Neurosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap34.45MEPS (ttm)-0.36
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B47.32EPS Q/Q-239.75%
Dividend-Sales Q/Q-
Insider Own17.63%Inst Own2.60%
Insider Trans0.00%Inst Trans-6.01%
Short Float9.97%Earnings-
Analyst Recom-Target Price-
Avg Volume40.69M52W Range0.11 - 3.91
Jun-30-25 02:00AM Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS (PR Newswire) +56.92%
Jun-24-25 05:00AM Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population (PR Newswire) +20.00%
Jun-18-25 07:00AM KLOTHO NEUROSCIENCES (KLTO) ANNOUNCES MUTUAL TERMINATION OF SHARE EXCHANGE AGREEMENT WITH SKYBELL TECHNOLOGIES (SKYBELL), TO CONTINUE ITS FOCUS ON THERAPEUTICS AND LONGEVITY PROGRAMS (PR Newswire)
Jun-16-25 07:00AM KLOTHO NEUROSCIENCES RAISES OVER $11 MILLION, RETIRES ALL DEBT, AND EXCEEDS NASDAQ STOCKHOLDERS' EQUITY REQUIREMENT (PR Newswire)
Jun-09-25 07:00AM KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("a-KLOTHO") (PR Newswire) +787.80%
07:00AM KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY AND HEALTHY LIFE SPAN - REPLACE A SILENCED GENE CALLED ALPHA-KLOTHO ("-KLOTHO") (PR Newswire)
Jan-08-25 11:00AM Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco (GlobeNewswire) -8.94%
Dec-09-24 11:00AM Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board (GlobeNewswire)
Dec-03-24 11:00AM Former Merck USA President Joins Klotho Neurosciences' Board of Directors (GlobeNewswire)
Oct-23-24 06:00AM Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor (GlobeNewswire) -18.57%
Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Omaha, NE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHARDAN CAPITAL MARKETS LLC10% OwnerJul 02 '24Sale2.05180,000368,4421,284,364Jul 02 06:34 PM
ARBE - Arbe Robotics Ltd - Stock Price Chart
TickerARBE [NASD]
CompanyArbe Robotics Ltd
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap175.62MEPS (ttm)-0.58
P/E-EPS this Y38.80%
Forward P/E-EPS next Y10.71%
PEG-EPS past 5Y-
P/S262.12EPS next 5Y25.72%
P/B2.67EPS Q/Q21.61%
Dividend-Sales Q/Q-70.80%
Insider Own28.36%Inst Own23.51%
Insider Trans0.00%Inst Trans-20.50%
Short Float9.89%EarningsMay 20/b
Analyst Recom1.67Target Price2.38
Avg Volume1.60M52W Range0.85 - 5.09
Arbe Robotics Ltd. develops radar and operating system for drones, automotive, and robots. It provides 4D imaging radar solution for autonomous vehicles. The company was founded by Kobi Marenko, Noam Arkind and Oz Fixman on 4th November, 2015 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Canaan Partners Israel (CPI) C10% OwnerJun 09 '25Proposed Sale1.80109,981198,109Jun 09 04:58 PM
Canaan Partners Israel (CPI) C10% OwnerMay 16 '25Proposed Sale1.70100,000170,240May 16 04:43 PM
Canaan Partners Israel (CPI) C10% OwnerMay 12 '25Proposed Sale1.5077,339116,264May 12 04:16 PM
Canaan Partners Israel (CPI) C10% OwnerApr 28 '25Proposed Sale1.5022,66134,084Apr 28 05:32 PM
Machness RamOfficerApr 02 '25Proposed Sale1.041,6351,700Apr 03 07:04 AM
DCTH - Delcath Systems Inc - Stock Price Chart
TickerDCTH [NASD]
CompanyDelcath Systems Inc
CountryUSA
IndustryMedical Devices
Market Cap444.39MEPS (ttm)-0.51
P/E-EPS this Y103.69%
Forward P/E20.21EPS next Y1741.65%
PEG-EPS past 5Y69.36%
P/S8.25EPS next 5Y-
P/B5.32EPS Q/Q106.07%
Dividend-Sales Q/Q530.26%
Insider Own15.84%Inst Own40.68%
Insider Trans0.00%Inst Trans29.41%
Short Float2.25%EarningsMay 08/b
Analyst Recom1.00Target Price24.29
Avg Volume586.20K52W Range7.17 - 18.23
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vukovic VojoCHIEF MEDICAL OFFICERJun 12 '25Option Exercise4.7842,000200,760168,882Jun 13 05:22 PM
MICHEL GERARD JCHIEF EXECUTIVE OFFICEROct 22 '24Option Exercise6.0016,66699,996319,334Oct 23 04:17 PM
110121314151617181920